News
Home>News & Events>Publications>CPAD>The Coalition Against Major Diseases: developing tools for an integrated drug development process for Alzheimer’s and Parkinson’s diseases
57
Related Posts
-
Alzheimer’s disease patient groups derived from a multivariate analysis of cognitive test outcomes in the Coalition Against Major Diseases dataset
-
Sex-specific patterns and differences in dementia and Alzheimer’s disease using informatics approaches
-
Building A Roadmap For Developing Combination Therapies For Alzheimer’s Disease
-
The Future Is Now: Model‐based Clinical Trial Design For Alzheimer’s Disease
-
Development Of A Unified Clinical Trial Database For Alzheimer’s Disease